The evolution of therapy for patients with stage IIIA (N2) lung cancer

Chest. 1997 Oct;112(4 Suppl):201S-202S. doi: 10.1378/chest.112.4_supplement.201s.

Abstract

This is a demonstrable case report and discussion of recent trends in neoadjuvant therapy for patients with locally advanced stage IIIA (N2) non-small cell lung cancer.

Publication types

  • Case Reports

MeSH terms

  • Antineoplastic Combined Chemotherapy Protocols / therapeutic use*
  • Bronchoscopy
  • Carcinoma, Non-Small-Cell Lung / classification
  • Carcinoma, Non-Small-Cell Lung / diagnostic imaging
  • Carcinoma, Non-Small-Cell Lung / drug therapy*
  • Cisplatin / administration & dosage
  • Follow-Up Studies
  • Humans
  • Lung Neoplasms / classification
  • Lung Neoplasms / diagnostic imaging
  • Lung Neoplasms / drug therapy*
  • Lymph Nodes / diagnostic imaging
  • Lymph Nodes / pathology
  • Male
  • Mediastinoscopy
  • Mediastinum
  • Middle Aged
  • Neoplasm Staging
  • Tomography, X-Ray Computed
  • Vinblastine / administration & dosage

Substances

  • Vinblastine
  • Cisplatin